B7H3-targeted fully-humanized chimeric antigen receptor, iNKT cell and application thereof
A chimeric antigen receptor, fully human technology, applied in the field of immunology and molecular biology, can solve the problems of cancer cell infiltration, curative effect decline, drug tolerance, etc., and achieve the effect of strong proliferation ability and elimination of tumor cells
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0121] Example 1 Preparation of fully human B7H3-CAR-iNKT
[0122] 1. Experimental method
[0123] (1) Preparation of iNKT
[0124] 1) Separation of PBMCs: collect peripheral blood from the donor, dilute the whole blood with an equal volume of normal saline, add the lymphocyte separation solution and the diluted blood to the centrifuge tube at a ratio of 1:2, centrifuge at 2000rpm / min for 20 minutes, and collect the buffy coat cells , washed twice with normal saline, and centrifuged at 1500rpm / min for 8 minutes to obtain PBMCs from peripheral blood mononuclear cells;
[0125] 2) Induce iNKT cells: resuspend PBMCs with lymphocyte medium, adjust the concentration to 2×10 6 / mL, add α-Galcer, IL-2, IL-21, IL-4 and GM-CSF, seed the cells in a 24-well plate, and place at 37°C, 5% CO 2 Incubator, observe the cell state every day, and change the medium in half every other day;
[0126] 3) Magnetic bead sorting of iNKT cells: Collect induced cells on the 10th day, resuspend with 5...
Embodiment 2
[0141] Example 2 Verification of the ability of fully human B7H3-CAR-iNKT cells to kill renal cancer cells in vitro
[0142] 1. Experimental method
[0143] (1) CFSE test to detect proliferation ability
[0144] CFSE staining: Collect B7H3.CAR-iNKT cells, wash the cells with 0.1% FBS / PBS and resuspend, add CFSE working solution for staining to a final concentration of 1.5 μM, incubate at room temperature for 10 minutes, add FBS and incubate at 37°C for 10 minutes to terminate After staining, wash the cells twice with 2% FBS / PBS, and finally resuspend the T cell medium for use;
[0145]Kidney cancer cells 786-O and OSRC-2 were plated overnight, and the above stained effector cells were added according to the effect-to-target ratio of 1:2, and the effector cell group alone was used as a control. After 5 days, the cells were collected, washed, and CFSE fluorescence was detected by flow cytometry Signal, to analyze the proliferation ability of B7H3.CAR-iNKT cells.
[0146] (2) ...
Embodiment 3
[0152] Example 3 Verification of fully human B7H3-CAR-iNKT cells clearing renal cancer xenografts in vivo
[0153] 1. Experimental method
[0154] Purchase 6-week-old male NCG mice and inject 2 × 10 via subcutaneous injection 6 OSRC-2-Ffluc-GFP was used to construct the subcutaneous xenograft tumor model of renal cancer in mice. After tumor formation on the 12th day, the mice were randomly divided into Ctrl group, iNKT group, and B7H3.CAR-iNKT group, with 5 mice in each group, 3 groups in total; On days 0 and 8, respectively, iNKT and B7H3.CAR-iNKT cells were infused into the tail vein for treatment, 5×10 6 / mouse; the Ctrl group was only infused with PBS; the therapeutic effect was observed by measuring the tumor volume twice a week, and the survival of CAR-iNKT in vivo was detected by blood collection from the submandibular vein, and the survival period of the mice was recorded.
[0155] 2. Experimental results
[0156] See the experimental results Figure 7 A-D, Figur...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com